SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock at a price of $16.75 per share, which includes the exercise in full by the underwriter of its option to purchase an […]
Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on Monday, June 5, 2017 SOUTH EASTON, MA —- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”) today announced a one-for-thirty reverse split of its common stock effective as of Monday, June 5, 2017. The shares underlying the Company’s outstanding convertible securities will […]
SEATTLE, June 01, 2017 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a price of $16.75 per share pursuant to its existing shelf registration statement. NanoString has […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an agreement to sell 2,750,000 shares of its common stock to Robert W. Baird & Co. Incorporated as the underwriter in an underwritten public offering pursuant to NanoString’s existing shelf registration statement. NanoString has […]
SYGNIS AG successfully completes Rights Offering and Private Placement * Rights offering and private placement significantly oversubscribed * Acquisition of Innova Biosciences Ltd. secured * Gross proceeds of EUR 10 million to cover transaction and integration costs and working capital Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced […]
CAMBRIDGE, MA — Ovation Life Sciences, LLC (Ovation) announced today the receipt of 1.5 million dollars in funding from StageDotO, and existing investors, including Longfellow Ventures. The company will use the funds to continue the development of its next-generation scientific data-layer-as-a-service platforms, built to accelerate the progress of life science by improving how the story of […]
SYGNIS AG receives binding commitment for the purchase of shares for up to EUR 3.5 million within the scope of the ongoing capital increases to finance the acquisition of Innova Biosciences Ltd. Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today received a binding commitment for the purchase of shares […]
– Contributing to people’s health by promoting the spread of genetic testing equipment in the healthcare field – Tokyo, Japan: Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) agreed to start a capital and business alliance (hereinafter, “the Alliance”) with Precision System Science Co., Ltd. (PSS) relating to the genetic testing business using the PCR*¹ method. […]
Precision System Science, Co., Ltd. (“PSS”) hereby announces that its Board of Directors has resolved at the meeting held on May 15, 2017 to conclude a capital and business alliance with Hitachi High-Technologies Corporation (“Hitachi High-Tech”) (this alliance hereinafter referred to as the “Capital and Business Alliance”) and to issue new shares through a third-party […]
Revenue rises to over EUR 2.5 billion – EBIT reaches EUR 384 million All segments contributed to this positive trend Position as market leader reinforced Asia continues to ensure dynamic growth Demand for digital solutions increases Positive outlook for second half of fiscal year OBERKOCHEN/Germany The ZEISS Group had a very successful end to the […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
